Ear cartilage injection may outperform PRP for knee arthritis
NCT ID NCT07453953
First seen Mar 15, 2026 · Last updated May 20, 2026 · Updated 7 times
Summary
This early-phase study tests a new treatment called Mytocel MSK, made from a patient's own ear cartilage, for knee osteoarthritis. It aims to repair cartilage and reduce pain better than standard PRP injections. The study will enroll 30 adults with mild-to-moderate knee arthritis and track pain, function, and cartilage changes for one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYTOCEL MSK WITH AMT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.